Experts say that if Trump follows through, the proposed tariffs could have far-reaching consequences for the cost and ...

The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers ...

Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose ...

Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.

Generic drugs account for more than 90 percent of prescriptions filled in the United States. The FDA insists that they “have the same high quality, strength, purity and stability as brand-name drugs.” ...

Companies that don’t build plants in the U.S. will face 100% levies that would then double in August 2029, Trump said on social media.

Trump plans to impose a 100% tariff on imported generic drugs in two years to bolster domestic manufacturing of these widely-used medications.

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

A Supreme Court case heard this week could give brand-name drugmakers longer monopolies, delay generic competition, and leave patients paying higher prices. When it comes to generic medications, ...

Have you ever tried to fill a prescription only to be turned away by your pharmacy because it’s out of stock? Drug shortages happen when there’s not enough supply of a drug to meet current or expected ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds. These ...

Share on Pinterest Federal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions of Zepbound and Mounjaro. MK Photo/Alamy Stock Photo Federal ...